Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

602
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
602
Glaucoma: Overview01:25

Glaucoma: Overview

796
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
796

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photodynamic therapy in neovascular age-related macular degeneration: Past or present in the era of second-generation anti-VEGF agents?

Archivos de la Sociedad Espanola de Oftalmologia·2026
Same author

Clinical ultrasound for the characterisation of obesity: beyond the body mass index.

Revista clinica espanola·2025
Same author

National study on the management of central serous chorioretinopathy.

Archivos de la Sociedad Espanola de Oftalmologia·2025
Same author

Positioning for the use of multivessel clinicalultrasound in vascular risk evaluation: VASUS+protocol. 2024 Recommendations of the Vascular Risk WorkingGroup of The Spanish Society of Internal Medicine (SEMI), Clinical Ultrasound Working Group of the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Hypertension-Spanish League for the Fight against Arterial Hypertension (SHE-LELHA).

Revista clinica espanola·2025
Same author

Profile of patients with atrial fibrillation treated in internal medicine departments in spain. SUMAMOS-FA-SEMI registry.

Revista clinica espanola·2025
Same author

Positioning for the use of multivessel clinical ultrasound in vascular risk evaluation: VASUS+ protocol. 2024 recommendations of the Vascular Risk Group, clinical ultrasound of the Spanish Society of Internal Medicine and Spanish Society of Hypertension and Vascular Risk.

Hipertension y riesgo vascular·2025

Related Experiment Video

Updated: Sep 20, 2025

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

2.8K

Position paper on retinal vein occlusion. SEMI-SERV.

J Pagán Escribano1, L Castilla Guerra2, E Guitierrez-Sánchez3

  • 1Servicio de Medicina Interna, Hospital General Universitario José María Morales Meseguer, Murcia, Spain.

Revista Clinica Espanola
|May 23, 2025
PubMed
Summary

Retinal vein occlusion (RVO) management requires addressing systemic factors like hypertension and diabetes. Comprehensive cardiovascular risk factor control is vital for treating RVO, implicated in 90% of cases.

Keywords:
Enfermedad venosa tromboembólicaOcclusionOclusiónRetinaRiesgo vascularThromboembolic venous diseaseVascular riskVeinVena

More Related Videos

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.3K
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.7K

Related Experiment Videos

Last Updated: Sep 20, 2025

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

2.8K
In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.3K
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.7K

Area of Science:

  • Ophthalmology
  • Cardiology
  • Vascular Medicine

Background:

  • Retinal vein occlusion (RVO) is a common retinal vascular disease.
  • It is linked to systemic conditions including hypertension, diabetes mellitus, dyslipidemia, and thrombophilias.
  • Cardiovascular risk factors are implicated in approximately 90% of RVO cases.

Purpose of the Study:

  • To provide a comprehensive review of retinal vein occlusion.
  • To cover pathophysiology, clinical manifestations, diagnosis, and treatment.
  • To incorporate the latest scientific evidence and expert recommendations.

Main Methods:

  • Literature review of current scientific evidence.
  • Analysis of expert recommendations for RVO management.
  • Synthesis of information on systemic and local factors in RVO.

Main Results:

  • RVO is strongly associated with modifiable cardiovascular risk factors.
  • Systemic management focusing on these factors is crucial for RVO treatment.
  • Differential diagnosis is important in specific RVO cases.

Conclusions:

  • A multidisciplinary approach integrating ophthalmological and systemic management is essential for RVO.
  • Rigorous control of hypertension, diabetes, and dyslipidemia is key.
  • Further research into RVO pathophysiology and treatment is warranted.